IL139817A - Non-hydrated gabapentin polymorpha process for thepreparation thereof and the use thereof for the p reparation of pharmaceutical grade gabapentin - Google Patents

Non-hydrated gabapentin polymorpha process for thepreparation thereof and the use thereof for the p reparation of pharmaceutical grade gabapentin

Info

Publication number
IL139817A
IL139817A IL13981799A IL13981799A IL139817A IL 139817 A IL139817 A IL 139817A IL 13981799 A IL13981799 A IL 13981799A IL 13981799 A IL13981799 A IL 13981799A IL 139817 A IL139817 A IL 139817A
Authority
IL
Israel
Prior art keywords
gabapentin
thepreparation
polymorpha
reparation
hydrated
Prior art date
Application number
IL13981799A
Other languages
English (en)
Other versions
IL139817A0 (en
Original Assignee
Medichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medichem Sa filed Critical Medichem Sa
Publication of IL139817A0 publication Critical patent/IL139817A0/xx
Publication of IL139817A publication Critical patent/IL139817A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL13981799A 1998-05-25 1999-05-10 Non-hydrated gabapentin polymorpha process for thepreparation thereof and the use thereof for the p reparation of pharmaceutical grade gabapentin IL139817A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801078A ES2137137B1 (es) 1998-05-25 1998-05-25 Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
PCT/ES1999/000127 WO1999061408A1 (fr) 1998-05-25 1999-05-10 Polymorphe de gabapentine non hydratee, son procede d'obtention et son utilisation pour l'obtention de gabapentine a usage pharmaceutique

Publications (2)

Publication Number Publication Date
IL139817A0 IL139817A0 (en) 2002-02-10
IL139817A true IL139817A (en) 2005-11-20

Family

ID=8303893

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13981799A IL139817A (en) 1998-05-25 1999-05-10 Non-hydrated gabapentin polymorpha process for thepreparation thereof and the use thereof for the p reparation of pharmaceutical grade gabapentin

Country Status (9)

Country Link
US (1) US6521787B1 (fr)
EP (1) EP1083164B1 (fr)
AU (1) AU3710699A (fr)
CA (1) CA2333408A1 (fr)
DE (1) DE69912773T2 (fr)
ES (1) ES2137137B1 (fr)
HU (1) HUP0102104A3 (fr)
IL (1) IL139817A (fr)
WO (1) WO1999061408A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1169060B1 (fr) 1999-04-09 2005-08-31 Euro-Celtique S.A. Composition de blocage du canal sodique et leur utilisation
ES2164527B1 (es) * 1999-04-26 2003-04-01 Medichen S A Procedimiento de obtencion de gabapentina de calidad farmaceutica.
PT1423168E (pt) 2001-09-03 2006-05-31 Newron Pharm Spa Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico
US6800782B2 (en) 2001-10-09 2004-10-05 Warner-Lambert Co. Anhydrous crystalline forms of gabapentin
ITMI20022071A1 (it) * 2002-10-01 2004-04-02 Erregierre Spa Processo di sintesi dell'acido 1-(aminometil)cicloesanacetico cloridato.
GB2413556B (en) * 2002-11-12 2007-03-14 Tianjin Kinsly Pharmaceutical A new crystal form of adefovir dipivoxil and its composition
WO2004106281A1 (fr) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Gabapentine cristallin
US7169812B2 (en) * 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
US20050187295A1 (en) * 2004-02-19 2005-08-25 Surendra Kalyan Processes for the preparation of gabapentin
US20110224435A1 (en) * 2007-08-07 2011-09-15 Ranbaxy Laboratories Limited Process for preparation of amorphous lopinavir
WO2010091257A1 (fr) * 2009-02-06 2010-08-12 Bach Pharma, Inc. Phtalazinediones de qualité pharmaceutique, procédé pour leur préparation et compositions pharmaceutiques les contenant
JP6283663B2 (ja) 2012-05-17 2018-02-21 ジェネンテック， インコーポレイテッド Ａｋｔを阻害するピリミジニルシクロペンタン化合物の非晶質形態、組成物およびその方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4960931A (en) * 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
US4894476A (en) 1988-05-02 1990-01-16 Warner-Lambert Company Gabapentin monohydrate and a process for producing the same
DE3928184A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
IL119890A (en) * 1996-12-24 2002-03-10 Teva Pharma Gabapentin form iii and preparation of gabapentin form ii

Also Published As

Publication number Publication date
HUP0102104A2 (hu) 2001-11-28
EP1083164B1 (fr) 2003-11-12
HUP0102104A3 (en) 2002-11-28
ES2137137B1 (es) 2000-08-16
AU3710699A (en) 1999-12-13
EP1083164A1 (fr) 2001-03-14
WO1999061408A1 (fr) 1999-12-02
DE69912773D1 (de) 2003-12-18
DE69912773T2 (de) 2004-09-30
US6521787B1 (en) 2003-02-18
CA2333408A1 (fr) 1999-12-02
IL139817A0 (en) 2002-02-10
ES2137137A1 (es) 1999-12-01

Similar Documents

Publication Publication Date Title
PT936908E (pt) Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
DE69921941D1 (de) Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln
PL315635A1 (en) Method of solubilising hardly pharmaceutically active substances
AU8166098A (en) Removal of biologically active agents
EP1017980A4 (fr) Procede d'identification de composes pharmaceutiquement actifs
IL139817A (en) Non-hydrated gabapentin polymorpha process for thepreparation thereof and the use thereof for the p reparation of pharmaceutical grade gabapentin
FR2767677B1 (fr) Microkeratome pour chirurgie optalmologique
EP1213018A4 (fr) Agents destines a la prevention et a au traitement des maladies des yeux
EP1039883A4 (fr) Methodes de traitement de maladies liees a l'apolipoproteine e
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
GB9515802D0 (en) Hiv protease inhibitors useful for the treatment of aids
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
GB9922710D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
GB9526691D0 (en) Medical use of proteases
IL120005A0 (en) Pharmaceutical compositions for the treatment of the eye
GB9817348D0 (en) Pharmaceutical use of esters
FI943989A0 (fi) Terapeuttisia tai ehkäiseviä aineita peroksilipidiin liittyviin sairauksiin
GB9508300D0 (en) HIV protease inhibtors for the treatment of aids
EP0914125A4 (fr) Inhibiteurs de la protease du vih utilises dans le traitement du sida
GB2329124B (en) Method of forming dose units of active agents
ZA963183B (en) Process for the depyrogenation of injectable pharmaceutical solutions
GB9615710D0 (en) Pharmaceutical preparations for the treatment of sarcocystosis
GB9506067D0 (en) Process for the destruction of halocarbons
IL143795A0 (en) Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections
DE59604915D1 (de) Entschwefelungsmittel zur koinjektions-behandlung von roheisenschmelzen

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees